Elevance Health Inc (ELV) concluded trading on Thursday at a closing price of $280.43, with 3.56 million shares of worth about $998.52 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.23% during that period and on July 24, 2025 the price saw a loss of about -5.45%. Currently the company’s common shares owned by public are about 224.84M shares, out of which, 224.79M shares are available for trading.
Stock saw a price change of -7.28% in past 5 days and over the past one month there was a price change of -25.50%. Year-to-date (YTD), ELV shares are showing a performance of -44.35% which decreased to -23.98% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $274.40 but also hit the highest price of $567.26 during that period. The average intraday trading volume for Elevance Health Inc shares is 2.05 million. The stock is currently trading -16.32% below its 20-day simple moving average (SMA20), while that difference is down -22.96% for SMA50 and it goes to -29.76% lower than SMA200.
Elevance Health Inc (NYSE: ELV) currently have 224.84M outstanding shares and institutions hold larger chunk of about 93.13% of that.
The stock has a current market capitalization of $63.15B and its 3Y-monthly beta is at 0.59. PE ratio of stock for trailing 12 months is 11.94, while it has posted earnings per share of $23.49 in the same period. Its PEG reads 2.25 while making debt-to-equity ratio of 0.69. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ELV, volatility over the week remained 4.45% while standing at 3.53% over the month.
Analysts are in expectations that Elevance Health Inc (ELV) stock would likely to be making an EPS of 5.89 in the current quarter, while forecast for next quarter EPS is 4.26 and it is 33.34 for next year. For the current quarter EPS, analysts have given the company a lowest target 4.47 which is 8.97 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 8.37 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -6.59% while it is estimated to increase by 7.78% in next year. EPS is likely to shrink at an annualized rate of 5.30% for next 5-years, compared to annual growth of 6.81% made by the stock over the past 5-years.
Coverage by Leerink Partners stated Elevance Health Inc (ELV) stock as a Market perform in their note to investors on July 18, 2025, suggesting a price target of $310 for the stock. On April 15, 2025, Robert W. Baird Downgrade their recommendations, while on March 17, 2025, Argus Upgrade their ratings for the stock with a price target of $450. Stock get an Equal-weight rating from Stephens on January 22, 2025.
